BIO-RAD LABORATORIES, INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2016 | — | $2.58B | $456.3M |
| FY2017 | — | $2.93B | $383.8M |
| FY2018 | — | $4.02B | $431.5M |
| FY2019 | — | $5.76B | $660.7M |
| FY2020 | — | $9.89B | $662.2M |
| FY2021 | — | $13.69B | $470.8M |
| FY2022 | $1.20B | $9.62B | $434.2M |
| FY2023 | $1.20B | $8.74B | $403.8M |
| FY2024 | $1.20B | $6.57B | $488.1M |
| FY2025 | $1.20B | $7.45B | $529.8M |